Literature DB >> 7400951

Serum protein binding of prednisolone in four species.

M L Rocci, N F Johnson, W J Jusko.   

Abstract

The protein binding of prednisolone in serum from humans, rabbits, dogs, and rats was determined by equilibrium dialysis. Two nonlinear least-squares regression programs were used to characterize transcortin and albumin binding of the steroid. The animal species differed markedly in their ability to bind prednisolone, but the rabbit was most similar to humans in transcortin concentration and affinity constant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400951     DOI: 10.1002/jps.2600690831

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.

Authors:  M L Huang; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits.

Authors:  G M Ferron; W J Jusko
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

3.  Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-09-03       Impact factor: 4.030

4.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.

Authors:  Vivaswath S Ayyar; Dawei Song; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 5.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

6.  Dose dependent pharmacokinetics of prednisone and prednisolone in man.

Authors:  J Q Rose; A M Yurchak; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

7.  Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.

Authors:  W A McAllister; C R Winfield; J V Collins
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  In vitro protein binding of cefonicid and cefuroxime in adult and neonatal sera.

Authors:  J M Benson; F D Boudinot; A T Pennell; F E Cunningham; J T DiPiro
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  Effect of inflammatory bowel disease on absorption and disposition of prednisolone.

Authors:  R L Milsap; D E George; S J Szefler; K A Murray; E Lebenthal; W J Jusko
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

10.  Absorption of prednisolone in patients with Crohn's disease.

Authors:  J A Shaffer; S E Williams; L A Turnberg; J B Houston; M Rowland
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.